Heterogenous group of tumors like Soft Tissue Sarcoma, in all pediatric and adult malignancies make around 12% and 1% respectively.(2)As per the Egyptian National Population-Based Cancer Registry Program in the year 2008-2011, 1.47% of all cases were STSs. Extremities being the ones frequently affected, they make around 59% of all sarcomas. The median age of onset is from 50-55 years with no ethnic/race predisposition. Soft Tissue Sarcoma in comparison to other tumorshas got its own unique features that up until today has made the understanding of this disease quite unclear and these are:- 1) The rarity of the disease. 2) The numerous histopathological subtypes. 3) Complex biological behavior. 4) Anatomical sites involvement. The aim of the work was to identify the pathological subtypes and criteria, and surgical options adopted for managing operable soft tissue sarcoma of the extremities. Immediately after obtaining a consent from the ethical committee of Alexandria University Faculty of medicine, the patients’ clinical details, pathological pattern of the disease and management modalities were obtained from the patients’ files. All the patients in the study had operable soft tissue sarcoma and they underwent surgical interventions.
Alin, A. (2021). CLINICOPATHOLOGICAL CRITERIA AND SURGICAL OPTIONS FOR PATIENTS WITH OPERABLE EXTREMITIES SOFT TISSUE SARCOMA. ALEXMED ePosters, 3(2), 46-47. doi: 10.21608/alexpo.2021.75429.1154
MLA
Abdiqani abdullahi Alin. "CLINICOPATHOLOGICAL CRITERIA AND SURGICAL OPTIONS FOR PATIENTS WITH OPERABLE EXTREMITIES SOFT TISSUE SARCOMA", ALEXMED ePosters, 3, 2, 2021, 46-47. doi: 10.21608/alexpo.2021.75429.1154
HARVARD
Alin, A. (2021). 'CLINICOPATHOLOGICAL CRITERIA AND SURGICAL OPTIONS FOR PATIENTS WITH OPERABLE EXTREMITIES SOFT TISSUE SARCOMA', ALEXMED ePosters, 3(2), pp. 46-47. doi: 10.21608/alexpo.2021.75429.1154
VANCOUVER
Alin, A. CLINICOPATHOLOGICAL CRITERIA AND SURGICAL OPTIONS FOR PATIENTS WITH OPERABLE EXTREMITIES SOFT TISSUE SARCOMA. ALEXMED ePosters, 2021; 3(2): 46-47. doi: 10.21608/alexpo.2021.75429.1154